Differential Diagnosis in Neuro-oncology Tapa dura - 2001 - 1st Edición

Información de la editorial

Most neurological lesions in cancer patients are progressive, have a profound influence on the quality of life and are life threatening. Managment of the situation requires rapid identification of the nature and location of the problem as the treatment outcome depends as much on the speed of diagnosis as on the subsequent therapy. While modern neuroimages provide invaluable clues to the diagnosis, they need to be interpreted in the light of clinical data. The clinical examination remains the cornerstone of the differential diagnosis of neurological lesions affecting the cancer patient. Neurological disorders are a consequence not only of primary tumours of the central and peripheral nervous system, but also of systemic malignancy. One in five patients with disseminated malignancy develop neurological complications other than neurogenic pain. The majority of neurological problems are a direct consequence of metastatic disease or the result of metabolic disorders; however, some disorders are due to anti-neoplastic treatments or the administration of drugs.